Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2007 August;98(4) > Minerva Medica 2007 August;98(4):287-98

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


eTOC

 

EDITORIAL  ENDOSCOPIC ULTRASOUND IN 2007


Minerva Medica 2007 August;98(4):287-98

language: English

New frontiers in therapeutic EUS: dreams, style exercises or actual possibilities

Buchner A. M., Wallace M. B.

Division of Gastroenterology and Hepatology Mayo Clinic Jacksonville, FL, USA


PDF  


The term therapeutic endoscopic ultrasound (EUS) refers to direct ultrasound guided placement of pharmaceuticals, devices and biological agents for the purpose of treating a disease or symptoms. The vast majority of EUS procedures in the world are performed for diagnostic purposes, although these lead directly to therapeutic decisions such as whether to treat diseases by local (including endoscopic) resection, surgery or chemotherapy. EUS imaging is providing directions for therapies in different conditions, such as 1) gastrointestinal (GI) diseases including luminal GI malignancies, 2) management of pancreatic pain by performing the celiac plexus block, 3) drainage of obstructed biliary and pancreatic ducts when standard ERCP methods have failed, and 4) lesions surrounding the gut wall, including adjacent organs (pancreas liver, etc) and mediastinum (e.g. non-small cell lung cancer staging). Experimental promising EUS applications include delivery of cytotoxic agents such as chemotherapy, gene therapy, and radioactive seeds. This article will review the diagnostic and therapeutic role of EUS in gastrointestinal as well as extra-intestinal diseases.

top of page

Publication History

Cite this article as

Corresponding author e-mail